Advertisement

Prioritization of Factors of Breast Cancer Treatment Using Fuzzy AHP

  • Hatice Camgoz-AkdagEmail author
  • Aziz Kemal Konyalioglu
  • Tugce Beldek
Conference paper
  • 17 Downloads
Part of the Lecture Notes in Management and Industrial Engineering book series (LNMIE)

Abstract

Breast cancer is a widespread disease that can both be seen at males or females. According to so many different factors such as age, sex, genetics, the shape and size of the tumor, environmental situations, and so on, that affects cancer type directly. With so many alternative cancer types and thus, treatment preference changes, it is vital to make the diagnosis as soon as possible to decide and start the treatment process. Diagnosis time is dependent on both technological equipment and also medical personnel. This study aims to support medical personnel, radiologists, doctors, surgeons, via proposing a multi-criteria decision model to find out which factor is more effective on the breast cancer type. Fuzzy Analytic Hierarchy process is used to prioritize factors of breast cancer treatment alternatives and results are compared to another study which already used Analytic Hierarchy Process but in certain conditions.

Keywords

Breast cancer Multi-criteria decision making Fuzzy Analytical hierarchy process Healthcare support systems 

References

  1. Borin TF, Arbab AS, Gelaleti GB, Ferreira LC, Moschetta MG, Jardim- Perassi BV, Fabri VA (2016) Melatonin decreases breast cancer metastasis by modulating Rho- associated kinase protein- 1 expression. J Pineal Res 60(1):3–15CrossRefGoogle Scholar
  2. Bozbura FT, Beskese A, Kahraman C (2007) Prioritization of human capital measurement indicators using fuzzy AHP. Expert Syst Appl 32(4):1100–1112CrossRefGoogle Scholar
  3. Camgöz-Akdağ H, Alemdar Ç, Aydın E (2019) A MCDM model design for HER2+ breast cancer treatment technique using AHP method. PONTE J. 75(1/1):160–172Google Scholar
  4. Chan FT, Kumar N, Tiwari MK, Lau HC, Choy KL (2008) Global supplier selection: a fuzzy-AHP approach. Int J Prod Res 46(14):3825–3857CrossRefGoogle Scholar
  5. Chang DY (1996) Applications of the extent analysis method on fuzzy AHP. Eur J Oper Res 95(3):649–655MathSciNetCrossRefGoogle Scholar
  6. Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, Cameron D (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355(26):2733–2743.  https://doi.org/10.1056/nejmoa064320CrossRefGoogle Scholar
  7. Gumus AT (2009) Evaluation of hazardous waste transportation firms by using a two step fuzzy-AHP and TOPSIS methodology. Expert Syst Appl 36(2):4067–4074MathSciNetCrossRefGoogle Scholar
  8. Huang CC, Chu PY, Chiang YH (2008) A fuzzy AHP application in government-sponsored R&D project selection. Omega 36(6):1038–1052CrossRefGoogle Scholar
  9. Hung ML, Ma HW, Yang WF (2007) A novel sustainable decision making model for municipal solid waste management. Waste Manag 27(2):209–219CrossRefGoogle Scholar
  10. Kahraman C, Cebeci U, Ulukan Z (2003) Multi-criteria supplier selection using fuzzy AHP. Logist Inf Manag 16(6):382–394CrossRefGoogle Scholar
  11. Kumar D, Rahman Z, Chan FT (2017) A fuzzy AHP and fuzzy multi-objective linear programming model for order allocation in a sustainable supply chain: a case study. Int J Comput Integr Manuf 30(6):535–551CrossRefGoogle Scholar
  12. Lee AH, Chen WC, Chang CJ (2008) A fuzzy AHP and BSC approach for evaluating performance of IT department in the manufacturing industry in Taiwan. Expert Syst Appl 34(1):96–107CrossRefGoogle Scholar
  13. Rostami R, Mittal S, Rostami P, Tavassoli F, Jabbari B (2016) Brain metastasis in breast cancer: a comprehensive literature review. J Neurooncol 127(3):407–414CrossRefGoogle Scholar
  14. Saaty TL (1980) The analytic hierarchy process: planning, priority setting, resources allocation. McGraw, New YorkzbMATHGoogle Scholar
  15. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Baselga J (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344(11):783–792CrossRefGoogle Scholar
  16. URL-1 Kadcyla may help you live longer (n.d.). https://www.kadcyla.com/patient/about-kadcyla/benefits-risks.html. Accessed 15 Apr 2018
  17. Wanchai A, Armer JM, Stewart BR, Lasinski BB (2016) Breast cancer-related lymphedema: a literature review for clinical practice. Int J Nurs Sci 3(2):202–207Google Scholar
  18. Zyoud SH, Kaufmann LG, Shaheen H, Samhan S, Fuchs-Hanusch D (2016) A framework for water loss management in developing countries under fuzzy environment: integration of Fuzzy AHP with Fuzzy TOPSIS. Expert Syst Appl 61:86–105CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Hatice Camgoz-Akdag
    • 1
    Email author
  • Aziz Kemal Konyalioglu
    • 1
  • Tugce Beldek
    • 1
  1. 1.Management Engineering Department, Management FacultyIstanbul Technical UniversityIstanbulTurkey

Personalised recommendations